跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,747 条关于
“VIB – KU Leuven”
全部
8,747
临床试验
7,746
药物
452
机构
40
资讯
509
3个月前
Scientists Discover Key Alzheimer's Tipping Point in Microglia That May Determine Who Gets Dementia
2年前
Augustine Therapeutics Raises €78 Million Series A to Advance Novel HDAC6 Inhibitor for Charcot-Marie-Tooth Disease
去年
Augustine Therapeutics Secures €78 Million to Advance HDAC6 Inhibitor for Charcot-Marie-Tooth Disease
10个月前
Robert Packard Center and ALS United Launch Joint Research Initiative to Target TDP-43 Pathways in ALS
6个月前
Researchers Uncover How Lecanemab Activates Brain's Immune Cells to Clear Alzheimer's Plaques
去年
Augustine Therapeutics Appoints Rie Schultz Hansen as CSO, Establishes Copenhagen Subsidiary to Advance HDAC6 Inhibitor Pipeline
去年
KU Leuven and UZ Leuven Launch €14 Million Advanced Therapy Production Facility
去年
KU Leuven Researchers Develop Dual-Agent Method to Permanently Silence HIV Virus
去年
eXmoor Pharma and KU Leuven Form Strategic Alliance to Accelerate AAV Gene Therapy Development
去年
KU Leuven Spin-off Hemastatx Develops First Therapy Targeting Root Cause of Severe Bleeding Disorder
第 1 页,共 51 页
上一页
下一页